Test Name |
Description |
CPT/HCPC Codesa |
Price |
Case Price/Cost |
SARS-CoV-2 RNA (COVID-19), Qualitative NAATb |
The test is designed to detect the virus that causes COVID-19 in respiratory specimens, for example, nasal or oral swabs. |
U0003
U0005 (when applicable) |
Quest will bill your health plan or the government $100.00 or $125.00 depending on the plan |
Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government |
SARS-CoV-2 Antibody (IgG), Spike, Semi-Quantitative test |
This test may detect an immune response to a prior or recent infection with SARS-CoV-2 (COVID-19).
|
86769 |
Quest will bill your health plan or the government $55.00c
|
Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government |
SARS-CoV-2 Serology (COVID-19) Antibodies (IgG, IgM), Immunoassay |
The test is designed to detect IgG and IgM antibodies in a blood sample that may indicate exposure to COVID-19. IgM antibodies to COVID-19 are generally detectable in blood several days after initial infection, with IgG antibodies typically reaching detectable levels simultaneously or 1-2 days later.
|
86769 x2
|
Quest will bill your health plan $110.00c |
Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government |
SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT |
This is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B.
|
87636 (1)
|
Quest will bill your health plan $511.70c |
Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government |
SARS-CoV-2 RNA (COVID-19), Influenza A/B, and RSV RNA, Qualitative NAAT |
This is a multitarget molecular test that aids in simultaneous qualitative detection and differentiation of COVID-19, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA among symptomatic patients. |
0241U |
Quest will bill your health plan $925.65c |
Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government |